The mutation status of a gene called IDH1 might have prognostic value for anaplastic astrocytomas, and that it may be worth exploring further whether IDH1 status can predict the best chemotherapy for these patients, a new study suggests.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1EWN9PG
No comments:
Post a Comment